(Q37837501)

24 August 2017

1 reference

title

Management of Cushing disease (English)

1 reference

24 August 2017

Nicholas A Tritos

1

1 reference

PubMed ID

21301487

24 August 2017

Beverly M K Biller

series ordinal

2

1 reference

PubMed ID

21301487

24 August 2017

Brooke Swearingen

series ordinal

3

1 reference

24 August 2017

8 February 2011

1 reference

Nature Reviews Endocrinology

24 August 2017

1 reference

24 August 2017

7

1 reference

24 August 2017

5

1 reference

24 August 2017

279-289

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2011.12

24 August 2017

0 references

cites work

Evaluation and treatment of Cushing's syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

A physiologic approach to diagnosis of the Cushing syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Diagnosis and complications of Cushing's syndrome: a consensus statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Complications in a contemporary series of patients who underwent transsphenoidal surgery for Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Long-term mortality after transsphenoidal surgery for Cushing disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Cushing's disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Late recurrences of Cushing's disease after initial successful transsphenoidal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Dynamics of serum cortisol levels after transsphenoidal surgery in a cohort of patients with Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Current state of the art in the diagnosis and surgical treatment of Cushing disease: early experience with a purely endoscopic endonasal technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Intraoperative conversion from endoscopic to microscopic approach for the management of sellar pathology: incidence and rationale in a contemporary series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

The complete normalization of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Clinical review: Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Assessment of cure and recurrence after pituitary surgery for Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

A combined dexamethasone desmopressin test as an early marker of postsurgical recurrence in Cushing's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Ectopic ACTH syndrome caused by bronchial carcinoid tumor indistinguishable from Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Delayed remission after transsphenoidal surgery in patients with Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Radiosurgery for Cushing's disease after failed transsphenoidal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

The efficacy of linear accelerator radiosurgery in the management of patients with Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Heavy-charged-particle radiosurgery of the pituitary gland: clinical results of 840 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Long-term follow-up results of postoperative radiation therapy for Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Medical therapy of Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Drugs in the medical treatment of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Ketoconazole treatment in Cushing's syndrome: experience in 34 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Acute hypoadrenalism and hepatotoxicity after treatment with ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Cushing's syndrome during pregnancy: personal experience and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Treatment of Cushing's disease by O,p'DDD. Survey of 62 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Nonhypnotic low-dose etomidate for rapid correction of hypercortisolaemia in cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Clinical practice. Prolactinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Cabergoline monotherapy in the long-term treatment of Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Dopamine agonists and the risk of cardiac-valve regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Valvular heart disease and the use of dopamine agonists for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Clinical Review#: Potential cardiac valve effects of dopamine agonists in hyperprolactinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Differential ligand-mediated pituitary somatostatin receptor subtype signaling: implications for corticotroph tumor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Merits and pitfalls of mifepristone in Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Surgery for Cushing's syndrome: an historical review and recent ten-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Bilateral adrenalectomy for refractory Cushing disease: a safe and definitive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease: a 10-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Long-term results of total adrenalectomy for Cushing's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Bilateral laparoscopic adrenalectomy for corticotrophin-dependent Cushing's syndrome: a review of the Mayo Clinic experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

ACTH-producing tumor of the pituitary gland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Gamma knife stereotactic radiosurgery of Nelson syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocorticotropin-secreting microadenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Treatment of Cushing's disease: a retrospective clinical study of the latest 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Early post-operative ACTH and cortisol as predictors of remission in Cushing’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Role of radiation therapy in clinical hormonally-active pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Gamma Knife surgery for Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Early repeat surgery for persistent Cushing's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long term follow-up studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Long-term follow-up of low-dose external pituitary irradiation for Cushing's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Octreotide may act as a radioprotective agent in acromegaly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Use of ketoconazole in the treatment of Cushing's disease and ectopic ACTH syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Cushing's syndrome in pregnancy--treatment with metyrapone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Aminoglutethimide and metyrapone in the management of Cushing's syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Experience with trilostane in the treatment of Cushing's syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Bilateral laparoscopic adrenalectomy for Cushing's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Laparoscopic adrenalectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Corticotroph tumor progression after adrenalectomy in Cushing's Disease: A reappraisal of Nelson's Syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Gadolinium DTPA enhanced MR imaging of ACTH-secreting microadenomas of the pituitary gland

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.12

Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas

31 March 2020

1 reference

12 December 2020

[Excision of pituitary adenomas by trans-sphenoidal approach.]

1 reference

12 December 2020

Persistent and recurrent hypercortisolism after transsphenoidal surgery for Cushing's disease

1 reference

12 December 2020

Long term follow-up of Cushing's disease treated with reserpine and pituitary irradiation

1 reference

12 December 2020

Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function.

1 reference

12 December 2020

Epidemiology and follow-up of Cushing's disease

1 reference

12 December 2020

Radiosurgery for pituitary tumors and craniopharyngiomas

1 reference

12 December 2020

[Pituitary gland imaging in Cushing's disease]

1 reference

12 December 2020

Laparoscopic adrenalectomy for adrenocorticotropin-dependent Cushing's syndrome

1 reference

12 December 2020

Risk factors and long-term outcome in pituitary-dependent Cushing's disease

1 reference

12 December 2020

Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis

1 reference

12 December 2020

The basophil adenomas of the pituitary body

1 reference

12 December 2020

Gamma knife radiosurgery in the treatment of Cushing disease: long-term results

1 reference

12 December 2020

The protracted effect of o,p'-DDD in Cushing's disease and its impact on adrenal morphogenesis of young human embryo

1 reference

12 December 2020

No effect of the PPAR-gamma agonist rosiglitazone on ACTH or cortisol secretion in Nelson's syndrome and Cushing's disease in vitro and in vivo.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2011.12

1 reference

24 August 2017

1 reference

PubMed ID

21301487